Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

151
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
151
Deindividuation00:57

Deindividuation

28.6K
Deindividuation is a form of social influence on an individual’s behavior such that the individual engages in unusual or non-normal behavior while in a group setting. Why? Because in these group settings, the individual no longer sees themselves as an individual anymore, disinhibiting their behavior and personal restraint.
28.6K
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism01:21

Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism

450
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
450
Masking and Demasking Agents01:19

Masking and Demasking Agents

3.0K
EDTA titrations may necessitate masking and demasking agents to temporarily protect a particular metal ion in a mixture from the EDTA reaction. These agents facilitate the sequential analysis of the metal ions by forming stable complexes with some—but not all—metal ions during certain steps.
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on...
3.0K
¹H NMR: Pople Notation01:09

¹H NMR: Pople Notation

2.1K
The Pople nomenclature system classifies spin systems based on the difference between their chemical shifts. Coupled spins are denoted by capital letters with subscripts indicating the number of equivalent nuclei. When the coupled nuclei have well-separated chemical shifts, they are assigned letters that are far apart in the alphabet, such as A and X. When the difference in chemical shifts is small, coupled nuclei are named using adjacent letters of the alphabet (AB, MN, or XY).
A proton...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Implementing informed consent in federated medical research: a blueprint designed to safeguard data subject rights in Germany.

Journal of translational medicine·2026
Same author

DataCastle: A Pragmatic Approach for Research and Real-World Data Management.

Studies in health technology and informatics·2026
Same author

Blaze: A High-Performance Open Source FHIR Server with Embedded CQL Evaluation Engine.

Studies in health technology and informatics·2026
Same author

Extended Barrier Precautions vs Hand Hygiene Alone and Neonatal Sepsis in Intensive Care Patients: The BALTIC Cluster-Randomized Clinical Trial.

JAMA network open·2026
Same author

A comprehensive European Colorectal Cancer Cohort dataset.

Scientific data·2026
Same author

Semantic alignment of the German Human Genome-Phenome Archive metadata model in Europe's genomics field.

Scientific data·2026
Same journal

Design and methodological development of a digital clinical safety training programme informed by a national framework: a New Zealand case study.

Methods of information in medicine·2026
Same journal

Panic Prediction from Digital Phenotyping: Subject-Level Cross-Validation Reveals Limited Between-Person Generalization.

Methods of information in medicine·2026
Same journal

Agent-Based Modeling Approach for Population Dynamics of the Biological Vector Aedes Aegypti.

Methods of information in medicine·2026
Same journal

A Statistical Framework for Person-centered Analysis of Digital Service Use in Public Health and Social Care.

Methods of information in medicine·2026
Same journal

Assessing the Quality of Electronic Discharge Summaries: A Cross-Sectional Study Using the Validated Spanish Version of the PDQI-9.

Methods of information in medicine·2026
Same journal

A Knowledge Graph-Driven Hypergeometric Efficacy Prediction Model for Classical Traditional Chinese Herbal Formulas.

Methods of information in medicine·2026
See all related articles

Related Experiment Video

Updated: Oct 29, 2025

Automated Robotic Liquid Handling Assembly of Modular DNA Devices
11:22

Automated Robotic Liquid Handling Assembly of Modular DNA Devices

Published on: December 1, 2017

12.6K

MAGICPL: A Generic Process Description Language for Distributed Pseudonymization Scenarios.

Galina Tremper1,2, Torben Brenner1,2, Florian Stampe1

  • 1Federated Information Systems, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Methods of Information in Medicine
|July 5, 2021
PubMed
Summary
This summary is machine-generated.

We developed MAGICPL, an XML-based language and Java components, to simplify and reuse pseudonymization processes for sensitive patient data in medical research, reducing development time.

More Related Videos

Functional Surface-immobilization of Genes Using Multistep Strand Displacement Lithography
11:05

Functional Surface-immobilization of Genes Using Multistep Strand Displacement Lithography

Published on: October 25, 2018

7.6K
A Method for Growing Bio-memristors from Slime Mold
07:46

A Method for Growing Bio-memristors from Slime Mold

Published on: November 2, 2017

9.1K

Related Experiment Videos

Last Updated: Oct 29, 2025

Automated Robotic Liquid Handling Assembly of Modular DNA Devices
11:22

Automated Robotic Liquid Handling Assembly of Modular DNA Devices

Published on: December 1, 2017

12.6K
Functional Surface-immobilization of Genes Using Multistep Strand Displacement Lithography
11:05

Functional Surface-immobilization of Genes Using Multistep Strand Displacement Lithography

Published on: October 25, 2018

7.6K
A Method for Growing Bio-memristors from Slime Mold
07:46

A Method for Growing Bio-memristors from Slime Mold

Published on: November 2, 2017

9.1K

Area of Science:

  • Health Informatics
  • Data Security
  • Medical Research

Background:

  • Pseudonymization is crucial for sensitive patient data in research.
  • Current bespoke solutions are resource-intensive and redundant.
  • Need for reusable and standardized pseudonymization components.

Purpose of the Study:

  • To propose a solution that facilitates reuse of pseudonymization components.
  • To reduce time and effort in building pseudonymization pipelines.
  • To encourage standardization in handling sensitive patient data.

Main Methods:

  • Analyzed existing data protection concepts for common features.
  • Developed MAGICPL, an XML-based descriptive language for pseudonymization.
  • Created a Java prototype implementation of reusable components with an HTTP API.

Main Results:

  • MAGICPL successfully implemented in three distinct projects.
  • Included re-implementation for the German Cancer Consortium.
  • Applied in a large-scale translational research network and an institute's service.

Conclusions:

  • The MAGICPL solution significantly reduced time and effort for pseudonymization pipeline development.
  • Productive use at multiple sites validated its efficiency and reusability.
  • Facilitates streamlined and standardized handling of sensitive medical data.